Response Rates to Anti–PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase-Reference-Cited by-同舟云学术

Response Rates to Anti–PD-1 Immunotherapy in Microsatellite-Stable Solid Tumors With 10 or More Mutations per Megabase

Author:

Valero Cristina¹,Lee Mark¹,Hoen Douglas¹,Zehir Ahmet²³,Berger Michael F.²³,Seshan Venkatraman E.⁴,Chan Timothy A.⁵⁶⁷,Morris Luc G. T.¹

Affiliation:

1. Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York

2. Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York

3. Marie-Josée and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center, New York, New York

4. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York

5. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York

6. Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, Ohio

7. Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Link

Reference9 articles.

5. Reliable Pan-Cancer Microsatellite Instability Assessment by Using Targeted Next-Generation Sequencing Data.;Middha;JCO Precis Oncol,2017

Cited by 151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献